Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BetaGlue

Request full access

A loco-regional radio-therapy platform for tumors

Milan, ItalyFounded 2009Biotech & Life Sciences

About BetaGlue

BetaGlue Technologies is an innovative startup focused on revolutionizing cancer treatment through localized internal radiotherapy. The company has developed a cutting-edge technology that allows for the highly controlled administration of radionuclides—radioactive substances used in medical treatments—directly into tumor masses or surgical beds after tumor removal. This method ensures maximum treatment efficacy while minimizing unwanted side effects both locally and throughout the body.

BetaGlue Technologies primarily serves the healthcare sector, specifically targeting oncologists and medical institutions that treat solid tumors. The company operates in the global medical device market, offering a unique solution that has been cleared for use worldwide.

The business model of BetaGlue Technologies is centered around the development and commercialization of its proprietary radiotherapy platform. The company generates revenue by selling its specialized medical devices and related compounds to hospitals, clinics, and cancer treatment centers. Additionally, BetaGlue may engage in partnerships or licensing agreements with other medical technology firms to expand its market reach and application.

The core technology involves a new anti-tumoral compound based on Yttrium-90 (90Y) microspheres, which are embedded in a biocompatible matrix. This compound is delivered to the target area using a proprietary delivery system that ensures precise administration of the required dose of energy. This intra-operative method is designed to maximize treatment efficacy and improve patient safety.

BetaGlue Technologies is backed by a global team of industry professionals with a proven track record in bringing innovative medical solutions to market. Their expertise and commitment to advancing cancer treatment make BetaGlue a promising player in the field of localized internal radiotherapy.

Source: Dealroom company data

At a glance

Status
Operational
Employees
23
Open positions
None listed
Dealroom signal
34.0/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotechnology, Oncology, EIC, EIC Fund, Radiotherapy, Hard Tech, Horizon Europe, ogr torino, DT and LS
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
EARLY VC✓Equity / VC Jan 2025 $0 — EIC Fund —
EARLY VC✓Equity / VC Dec 2024 $6.6M $44M Fondazione ENEA Tech ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

BetaGlue website traffic

Latest recorded traffic for BetaGlue is 850 monthly website visits, down 15% over the last three months. BetaGlue's team declined 4.2% over the past year.

Latest monthly visits850 3-month web change-15% 1-year team growth-4.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BetaGlue in the Milan ecosystem

Live from Dealroom

The BetaGlue office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A10 investors entered at this stage

  • Innogest Capital
  • Panakès Partners
  • NEVA SGR
  • LIFTT
  • Romed
  • Profequycapital
  • Fin Posillipo
  • EIC Fund
  • Giovanni Cerutti
  • Fondazione ENEA Tech
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇮🇹 Italy61.1%
🇺🇸 United States16.7%
🇫🇷 France11.1%
🇬🇧 United Kingdom5.6%
🇧🇪 Belgium5.6%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BetaGlue on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BetaGlue’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.